Market Research NewsNews

Asia Pacific Cholesterol Testing Market Competitive Landscape, Trends, Market Concentration Rate, Business Strategies 2025 by F. Hoffmann-La Roche Ltd, Siemens AG and Abbott

Asia Pacific Cholesterol Testing Market By Product Type (Test Kits, Testing Strips), By Test (Lipid Panel Test/Complete Lipid Profile {Total Cholesterol Test, HDL Cholesterol Test, LDL Cholesterol Test, Triglycerides/VLDL Cholesterol Test}, By Test Type (Non-Invasive, Invasive), By Prescription Mode (Over The Counter, Prescription Based), By End-Users (Clinics, Hospitals, Ambulatory Centers, Homecare, Diagnostic Centers), By Countries (China, Japan, India, South Korea, Australia, Thailand, Malaysia, Singapore, Indonesia, Philippines and Rest of APAC)- Industry Trends and Forecast to 2025

Asia Pacific Cholesterol Testing Market is expected to reach USD 1,959.83 million by 2025 from USD 1,048.15 million in 2017, at a CAGR of 8.2% in the forecast period 2018 to 2025. The new market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.

Get Sample Copy of Report @ https://databridgemarketresearch.com/request-a-sample/?dbmr=asia-pacific-cholesterol-testing-market

Key Points: Asia Pacific Cholesterol Testing Market

  • In 2017, the Asia Pacific cholesterol testing market is dominated by F. Hoffmann-La Roche Ltd, followed by Siemens AG and Abbott
  • Test Kits segment is dominating the Asia Pacific cholesterol testing
  • The cholesterol testing market in the Asia Pacific region is leading in China.

 Table of Contents:

  1. INTRODUCTION 
1.1. OBJECTIVES OF THE STUDY
1.2. MARKET DEFINITION
1.3. OVERVIEW OF Asia Pacific Cholesterol Testing Market CHOLESTEROL TESTING MARKET
1.4. CURRENCY AND PRICING
1.5. LIMITATION
1.6. MARKETS COVERED
  1. MARKET SEGMENTATION
2.1. MARKETS COVERED
2.2. GEOGRAPHIC SCOPE
2.3. YEARS CONSIDERED FOR THE STUDY
2.4. CURRENCY AND PRICING
2.5. RESEARCH METHODOLOGY
2.6. PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7. SECONDARY SOURCES
2.8. ASSUMPTIONS 
  1. EXECUTIVE SUMMARY 
  1. MARKET OVERVIEW
4.1. DRIVERS 
4.1.1. TECHNOLOGICAL ADVANCEMENTS IN CHOLESTEROL TESTING
4.1.2. GROWING NUMBER OF CARDIOVASCULAR DISEASES AND OBESITY
4.1.3. HIGHER GROWING NUMBER OF GERIATRIC POPULATION
4.1.4. RISING AWARENESS AND ACCEPTANCE OF PREVENTIVE HEALTHCARE
4.1.5. INCREASING CHOLESTEROL HOME/SELF-TESTING MARKET 
4.2. RESTRAINTS 
4.2.1. LACK OF KNOWLEDGE ABOUT NEW TREATMENT PRACTICES
4.2.2. REGULATORY POLICIES
4.3. OPPORTUNITIES
4.3.1. HIGH GROWTH POSSIBILITY IN DEVELOPING COUNTRIES
4.3.2. PATIENT-INITIATED TESTING 
4.4. CHALLENGES 
4.4.1. PATIENT DATA SECURITY
  1. PREMIUM INSIGHTS
6 Asia Pacific Cholesterol Testing Market, BY PRODUCT TYPE
6.1. OVERVIEW
6.2. TESTING STRIPS
6.3. TEST KITS
  1. Asia Pacific Cholesterol Testing Market, BY TEST
7.1. OVERVIEW
7.2. LIPID PANEL TEST/COMPLETE LIPID PROFILE
7.2.1. TOTAL CHOLESTEROL TEST
7.2.2. HDL CHOLESTEROL TEST
7.2.3. LDL CHOLESTEROL TEST
7.2.4. TRIGLYCERIDES/VLDL CHOLESTEROL TEST
7.3. APOLIPOPROTEIN B TEST
7.4. APOLIPOPROTEIN A-1 TEST
7.5. APOE GENOTYPING TEST
7.6. APOLIPOPROTEIN CII
7.7. OTHERS
  1. Asia Pacific Cholesterol Testing Market, BY TEST TYPE
8.1. OVERVIEW
8.2. NON-INVASIVE
8.3. INVASIVE
  1. Asia Pacific Cholesterol Testing Market, BY PRESCRIPTION MODE
9.1. OVERVIEW
9.2. OVER THE COUNTER
9.3. PRESCRIPTION BASED
  1. Asia Pacific Cholesterol Testing Market, BY END-USERS
10.1. OVERVIEW
10.2. CLINICS
10.3. HOSPITALS
10.4. AMBULATORY CENTERS
10.5. HOMECARE
10.6. DIAGNOSTIC CENTERS
 
  1. Asia Pacific Cholesterol Testing MarketBY GEOGRAPHY
  2. Asia Pacific Cholesterol Testing Market, COMPANY LANDSCAPE
  3. COMPANY PROFILES
  4. RELATED REPORTS

Request For TOC@ https://databridgemarketresearch.com/toc/?dbmr=asia-pacific-cholesterol-testing-market

Market Segmentation: 

  • The Asia Pacific cholesterol testing market is segmented on the basis of product type, test, test type, prescription mode, and end-users. The report provides data for 2016 to 2025, 2017 being the current year while 2018 to 2025 is the forecast period for the report.
  • The Asia-Pacific cholesterol testing market is segmented based on product type into testing strips and test kits. In 2018, test kits segment is expected to dominate the Asia-pacific cholesterol testing market with 62.4% market share and is expected to reach USD 1,231.61 million by 2025, growing at the highest CAGR of 8.3% in the forecast period 2018 to 2025.
  • The Asia-Pacific cholesterol testing market is segmented on the basis of test into lipid panel test/complete lipid profile, apolipoprotein b test, apolipoprotein A-1 test, APOE genotyping test, apolipoprotein CII and others. In 2018, lipid panel test/complete lipid profile segment is expected to dominate the Asia-pacific cholesterol testing market with 43.0% market share and is expected to reach USD 870.41 million by 2025, growing at the highest CAGR of 8.8% in the forecast period 2018 to 2025.
  • The Asia-Pacific cholesterol testing market is segmented on the basis of test type into non-invasive and invasive. In 2018, invasive market segment is expected to dominate the Asia-pacific cholesterol testing market with 72.8% market share and is expected to reach USD 1,405.51 million by 2025, growing at a CAGR of 8.0% in the forecast period 2018 to 2025. However, non-invasive is expected to grow at the highest CAGR of 8.8% in the forecast period, and is expected to reach USD 554.32 million in 2025 from USD 283.74 million in 2017.
  • The Asia-pacific cholesterol testing market is segmented on the basis of prescription mode into over the counter and prescription based. In 2018, prescription based market segment is expected to dominate the Asia-pacific cholesterol testing market with 79.2% market share and is expected to reach USD 1,577.77 million by 2025, growing at the highest CAGR of 8.5% in the forecast period 2018 to 2025.
  • The Asia-Pacific cholesterol testing market is segmented on the basis of prescription mode into end users, clinics, hospitals, ambulatory centers, homecare and diagnostic centers. In 2018, hospitals are expected to dominate the Asia-pacific cholesterol testing market with 47.2% market share and are expected to reach USD 953.99 million by 2025, growing at the highest CAGR of 8.7% in the forecast period 2018 to 2025

To Enquire Regarding This Report @ https://databridgemarketresearch.com/inquire-before-buying/?dbmr=asia-pacific-cholesterol-testing-market

Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, South America, MEA, Europe or Asia | Mail us at sopan.gedam@databridgemarketresearch.com

 

 

 

Tags

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Close